„Thalidomid“
Suchergebnisse
1.000+ Treffer
-
Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention
-
Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials
-
Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept
-
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression
-
Modulation of radiation-induced oral mucositis by thalidomide – Preclinical studies
-
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy
-
Stereoselective interactions and liquid chromatographic enantioseparation of thalidomide on cyclodextrin-bonded stationary phases
-
Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China
-
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
-
Front Cover: Multigram Synthesis of 3‐Azabicyclo (3.1.1) heptane Derivatives Including Bicyclic Thalidomide Analogs (Eur. J. Org. Chem. 17/2025)
-
Thalidomid-Studien
-
Der Contergan-Fall: eine unvermeidbare Arzneimittelkatastrophe? – Zur Geschichte des Arzneistoffs Thalidomid
-
Cover Picture: Enantiomerization Mechanism of Thalidomide and the Role of Water and Hydroxide Ions (Chem. Eur. J. 45/2012)
-
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
-
Basiswissen Contergan – wie eine ganzheitliche medizinische Versorgung contergangeschädigter Menschen gelingt
-
Pilot Study on the Efficacy and Safety of Thalidomide in Transfusion-Dependent and Non-transfusion-Dependent Thalassemia: A Prospective, Non-randomized Interventional Study
-
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival
-
Leben mit Contergan – Geschädigte, Angehörige und Freunde berichten über die Auswirkungen des Arzneimittels
-
Dynamische MRT der Lendenwirbelsäule zur Beurteilung der Mikrozirkulation unter anti-angiogenetischer Therapie bei Patienten mit myelodysplastischen Syndromen
-
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment